GLP-1 TV · Clinician
Ozempic Made Me Depressed
Today’s cheapest semaglutide$39/mo at Wellmedr, sale price.Compare all semaglutide prices Price read 22 Nov 2026 from the seller’s own page, ranked by price alone. That price is a compounded drug, and compounded drugs are not FDA-approved. Not from the video’s creator.Our summary
In this video, the speaker, who presents as an obesity expert, responds to news that the European Union is investigating whether semaglutide, the molecule in Ozempic, is linked to depression and suicidal thoughts in some people. He says many viewers asked him whether this is possible and whether they should worry. He stresses that any link to depression or suicidal ideation needs to be taken seriously and properly investigated.
Published by Dr. Dan | Obesity Expert on YouTube
As published by the channel. Not medical advice, and not an endorsement.
What else the video covers
He explains that semaglutide is a GLP-1 receptor agonist that amplifies a hormone the body already makes after meals, which helps with fullness and with bringing blood sugar back down. On the mechanism for mood effects, he says there are no good answers, only speculation. Ideas he lists include reduced pleasure from food and other activities because the drug acts on the brain's reward centers, lower energy from lower blood sugar, and poor nutrition from eating less.
He then points to a 2018 meta-analysis of bariatric surgery patients, which he says found suicide rates two times higher than BMI-matched controls and suicide and self-harm attempts four times higher. His main focus is unmet expectations: he says people expect to lose more weight, and faster, than clinicians expect, and that people with obesity often carry internalized weight bias and blame themselves. He describes how feeling a lack of control can lead to anxiety and then hopelessness. He says this is partly speculation and partly his clinical experience. His advice is for clinicians to screen and monitor, for patients to tell their primary care team and supports about mood changes, and for society to focus less on the scale.
Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.
Takeaways
The main points, in the order they come up. Tap a time to play from there.
- 0:00 The speaker says the European Union is investigating whether semaglutide may be linked to depression and suicidal thoughts, and that this deserves serious attention.
- 1:01 He explains that semaglutide mimics the GLP-1 hormone to increase fullness and lower blood sugar, but says the cause of any mood effect is unknown.
- 2:36 He lists speculative ideas, including less pleasure from food and activities, lower energy from lower blood sugar, and inadequate nutrition.
- 3:37 He cites a 2018 meta-analysis in which bariatric surgery patients had higher suicide and self-harm rates than matched controls.
- 5:08 He argues that unmet expectations about weight loss, combined with internalized weight bias, could lead to hopelessness and depression.
- 8:43 He advises clinicians to screen and monitor, and tells patients to report mood changes to their primary care team and lean on their supports.
What the video says
As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.
- Medication
- Ozempic
- Side effects mentioned
- fatigue
Questions this video answers
Can Ozempic cause depression?
The speaker says the European Union is investigating whether semaglutide is linked to depression and suicidal thoughts. He says there is not a lot of concrete evidence yet, and that the ideas he discusses are partly speculation and partly his clinical experience.
Why might Ozempic affect mood?
According to the speaker, possible explanations include reduced pleasure from food and usual activities because the drug acts in the brain's reward centers, lower energy from lower blood sugar, and not getting enough nutrition. He also points to unmet weight loss expectations and self-blame.
What should I do if my mood changes while taking Ozempic?
The speaker says to follow up with your primary care team if you notice changes in your mood or mental health. He also recommends reaching out to friends, family and other supports and telling them what is going on.
Videos on the same question
The closest videos in the library by what is said in them, not by title.
Ozempic Made Me Depressed: Update | Dr. Dan | Obesity ExpertThe speaker gives an update on whether GLP-1 medications such as Wegovy and Ozempic are linked to depression and suicidal ideation.- Already on semaglutide? What your next month costs at every programToday’s lowest is $39/mo. Every program ranked by price alone. Compounded drugs are not FDA-approved.
Wegovy & Ozempic: Do They Cause Depression or Improve Mood? | Dr. Dan | Obesity ExpertThe speaker, an obesity expert, takes up the question of whether Wegovy, Ozempic and related GLP-1 medications cause depression or suicidal ideation.
Ozempic Is Both Better And Worse Than You ThinkThis video looks at semaglutide, sold under brand names such as Ozempic and Wegovy, and the range of effects it can have beyond blood sugar and weight loss.
Ozempic use & mental health concernsThis segment looks at Ozempic and the worry that it can cause too much weight loss and affect mental health.
Are weight loss drugs causing depression and anxiety? | Health HubThis Health Hub segment looks at whether weight loss drugs are linked to depression and anxiety.
Read next
Our guides closest to what this video covers, with prices checked weekly.
- Semaglutide for weight loss: which version, and what each costs
Semaglutide is the molecule. For weight loss the FDA-approved version is Wegovy, sold as a weekly pen and a daily tablet. Ozempic is the same molecule approved for type 2 diabetes, so using it for weight is off-label. Compounded semaglutide uses semaglutide as its active ingredient, comes from a compounding pharmacy, is not FDA-approved, and is what most cash buyers actually take because it costs a fraction of the brand. All three produce the same side effects. What differs is the approval, the oversight and the price.
- Mounjaro vs Ozempic, and the trial everyone quotes about it
Mounjaro is tirzepatide and Ozempic is semaglutide: different molecules, not two brands of the same drug. Both are approved for type 2 diabetes, and the weight-loss versions are Zepbound and Wegovy. In the one head-to-head trial, SURMOUNT-5, tirzepatide produced 20.2% mean body-weight loss at 72 weeks against semaglutide's 13.7%. The detail almost every page omits: that trial dosed semaglutide to 2.4 mg in people without diabetes, which is the Wegovy range. Ozempic tops out at 2 mg. The famous result did not test Ozempic's dose range.
- Ozempic for weight loss, and where the ladder runs out
Ozempic is approved for type 2 diabetes, not for weight loss. Taking it to lose weight is off-label, which is legal, extremely common, and a prescriber's decision. The consequence nobody mentions is the ceiling: Ozempic's doses stop at 2 mg while Wegovy, the same molecule approved for weight, goes to 2.4 mg with a 7.2 mg strength above that. Someone using Ozempic for weight eventually runs out of ladder, and switching brand is the usual answer.
Next steps
Ozempic prices
Find more like it
Weigh-in and resultsMood and mental healthHow it worksFatigue
Up next
More from this collection
Watched it? See what it costs.
Every GLP-1 program we track, ranked by what actually leaves your account.




















